Skip to content
Catalyst

PapersPMID:17072885

The efficacy of Silybum marianum (L.) Gaertn. (silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial.

Phytotherapy research2006The record ↗

findings
7
compound
1
endpoints
7
PMID:17072885
  1. Finding, very limited evidencelowersGlycated haemoglobin (HbA1c)
  2. Finding, very limited evidencelowersFasting blood glucose
  3. Finding, very limited evidencelowersTotal cholesterol (TC)
  4. Finding, very limited evidencelowersLDL cholesterol
  5. Finding, very limited evidencelowersTriglycerides
  6. Finding, very limited evidencelowersAspartate aminotransferase
  7. Finding, very limited evidencelowersAlanine aminotransferase
Study, every finding
RCT
Dose studied, every finding
silymarin 200 mg tablet three times daily for 4 months
Population, every finding
adults with type II diabetes, conventional therapy continued in both arms

Study record

Design
randomised controlled trial
Species
human
Population
type II diabetic patients on conventional therapy
Participants
51
Comparator
placebo
Duration
122 days
Endpoints measured
14